yves collette

Documents

Identifiants chercheurs

yves-collette
ResearcherId : F-2270-2013
0000-0001-5359-7099
Google Scholar : https://scholar.google.com/citations?user=InPoGP0AAAAJ&hl=fr&oi=ao
IdRef : 070509891
ResearcherId : http://www.researcherid.com/rid/F-2270-2013

Présentation

Publications

	C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3 -Mutant Leukemia Marie Sabatier , Rudy Birsen , Laura Lauture , Sarah Mouche , Paolo Angelino Cancer Discovery, 2023, 13 (7), pp.1720-1747. ⟨10.1158/2159-8290.CD-22-0411⟩ Article dans une revue hal-04166110v1
	From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia Magali Saez-Ayala , Laurent Hoffer , Sébastien Abel , Khaoula Ben Yaala , Benoit Sicard Nature Communications, 2023, 14 (1), pp.3079. ⟨10.1038/s41467-023-38668-2⟩ Article dans une revue hal-04237671v1
	Downregulation of stromal syntenin sustains AML development Raphael Leblanc , Rania Ghossoub , Armelle Goubard , Rémy Castellano , Joanna Fares EMBO Molecular Medicine, 2023, 15 (11), ⟨10.15252/emmm.202317570⟩ Article dans une revue hal-04532862v1
	CRCM5484: A BET- BDII Selective Compound With Differential Anti-Leukemic Drug Modulation Kendall Carrasco , Camille Montersino , Carine Derviaux , Magali Saez-Ayala , Laurent Hoffer Journal of Medicinal Chemistry, 2022, pp.acs.jmedchem.1c02168. ⟨10.1021/acs.jmedchem.1c02168⟩ Article dans une revue hal-03624836v1
	Antimicrobial and cytotoxic effects of marine sponge extracts Agelas clathrodes, Desmapsamma anchorata and Verongula rigida from a Caribbean Island Julie Piron , Stéphane Betzi , Jessica Pastour , Audrey Restouin , Remy Castellano PeerJ, 2022, 10, pp.e13955. ⟨10.7717/peerj.13955⟩ Article dans une revue hal-03803766v1
	Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response Aude de Gassart , Kieu-Suong Le , Patrick Brune , Sophie Agaugué , Jennifer Sims Science Translational Medicine, 2021, 13 (616), ⟨10.1126/scitranslmed.abj0835⟩ Article dans une revue inserm-03540734v1
	H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines Andria Rakotomalala , Quentin Bailleul , Clara Savary , Mélanie Arcicasa , Maud Hamadou Cancers, 2021, 13 (21), pp.5551. ⟨10.3390/cancers13215551⟩ Article dans une revue hal-03418323v1
	Synergy and allostery in ligand binding by HIV-1 Nef Abdullah Aldehaiman , Afaque A Momin , Audrey Restouin , Luyao Wang , Xiaoli Shi Biochemical Journal, 2021, 478 (8), pp.1525 - 1545. ⟨10.1042/bcj20201002⟩ Article dans une revue hal-03380308v1
	Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia Lucille Stuani , Marie Sabatier , Estelle Saland , Guillaume Cognet , Nathalie Poupin Journal of Experimental Medicine, 2021, 218 (5), pp.e20200924. ⟨10.1084/jem.20200924⟩ Article dans une revue hal-03563454v1
	The NANOTUMOR consortium - Towards the Tumor Cell Atlas Florent Colin , Kristine Schauer , Ali Hamiche , Pierre Martineau , Jean-Paul Borg Biology of the Cell, 2021, 113 (6), pp.272-280. ⟨10.1111/boc.202000135⟩ Article dans une revue hal-03169719v1
	ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells Florent Amatore , Nicolas Ortonne , Marc Lopez , Florence Orlanducci , Rémy Castellano Blood Advances, 2020, 4 (20), pp.5203-5214. ⟨10.1182/bloodadvances.2020002395⟩ Article dans une revue hal-03152734v1
	ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells Florent Amatore , Nicolas Ortonne , Marc Lopez , Florence Orlanducci , Rémy Castellano Blood Advances, 2020, 4 (20), pp.5203-5214. ⟨10.1182/bloodadvances.2020002395⟩ Article dans une revue hal-03623228v1
	In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor Jeremy Ariey‐bonnet , Kendall Carrasco , Marion Le Grand , Laurent Hoffer , Stéphane Betzi Molecular Oncology, 2020, 14, pp.3083 - 3099. ⟨10.1002/1878-0261.12810⟩ Article dans une revue hal-02989358v1
	A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency Chantal Lagresle-Peyrou , Aurélien Olichon , Hanem Sadek , Philippe Roche , Claudine Tardy Haematologica, inPress, ⟨10.3324/haematol.2019.230250⟩ Article dans une revue hal-02545998v1
	ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells Florent Amatore , Nicolas Ortonne , Marc Lopez , Florence Orlanducci , Rémy Castellano Blood Advances, 2020, 4 (20), pp.5203-5214. ⟨10.1182/bloodadvances.2020002395⟩ Article dans une revue inserm-03038313v1
	A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study A. Collignon , M. A Hospital , C. Montersino , F. Courtier , A. Charbonnier Blood Cancer Journal, 2020, 10 (6), pp.64. ⟨10.1038/s41408-020-0330-5⟩ Article dans une revue inserm-03038330v1
	Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells Amélie Fouqué , Olivier Delalande , Mickael Jean , Rémy Castellano , Emmanuelle Josselin Journal of Medicinal Chemistry, 2019, 62 (20), pp.9339-9340. ⟨10.1021/acs.jmedchem.9b01578⟩ Article dans une revue hal-02526957v1
	A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells Abir Arfaoui , Claire Rioualen , Violette Azzoni , Guillaume Pinna , Pascal Finetti EMBO Molecular Medicine, 2019, 11 (10), pp.e9930. ⟨10.15252/emmm.201809930⟩ Article dans une revue hal-02539524v1
	Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach Laurent Hoffer , Yuliia Voitovich , Brigitt Raux , Kendall Carrasco , Christophe Muller Journal of Medicinal Chemistry, 2018, 61 (13), pp.5719-5732. ⟨10.1021/acs.jmedchem.8b00653⟩ Article dans une revue hal-02067797v1
	Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities Aude Le Roy , Thomas Prebet , Remy Castellano , Armelle Goubard , Florence Riccardi Frontiers in Immunology, 2018, 9, pp.977. ⟨10.3389/fimmu.2018.00977⟩ Article dans une revue hal-01791593v1
	Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients Norbert Vey , Marie Anne Hospital , Aude Collignon , Yves Collette , Daniel Birnbaum Blood, 2018, 132 (1), ⟨10.1182/blood-2018-99-119263⟩ Article dans une revue hal-02143630v1
	JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia Maria de Grandis , Florence Bardin , Cyril Fauriat , Christophe Zemmour , Abdessamad El-Kaoutari Cancer Research, 2017, 77 (23), pp.6627-6640. ⟨10.1158/0008-5472.CAN-17-1223⟩ Article dans une revue hal-01789603v1
	Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism Thomas Farge , Estelle Saland , Fabienne de Toni , Nesrine Aroua , Mohsen Hosseini Cancer Discovery, 2017, 7 (7), pp.716-735. ⟨10.1158/2159-8290.cd-16-0441⟩ Article dans une revue inserm-02465205v1
	Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer M. M-Rabet , O. Cabaud , E. Josselin , P. Finetti , R. Castellano Annals of Oncology, 2017, ⟨10.1093/annonc/mdw678⟩ Article dans une revue hal-01787533v1
	Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer Tania M. Puvirajesinghe , François Bertucci , Ashish Jain , Pierluigi Scerbo , Edwige Belotti Nature Communications, 2016, 7, pp.10318. ⟨10.1038/ncomms10318⟩ Article dans une revue hal-01447570v1
	BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia. Audrey Benyamine , A. Le Roy , Emilie Mamessier , J. Gertner-Dardenne , C. Castanier OncoImmunology, 2016, ⟨10.1080/2162402X.2016.1146843⟩ Article dans une revue inserm-01416288v1
	Protein-Protein Interaction Inhibition (2P21)-Oriented Chemical Library Accelerates Hit Discovery Sabine Milhas , Brigitt Raux , Stéphane Betzi , Carine Derviaux , Philippe Roche ACS Chemical Biology, 2016, 11 (8), pp.2140-2148. ⟨10.1021/acschembio.6b00286⟩ Article dans une revue hal-01439116v1
	Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins Brigitt Raux , Yuliia Voitovich , Carine Derviaux , Adrien Lugari , Etienne Rebuffet Journal of Medicinal Chemistry, 2016, 59 (4, SI), pp.1634-1641. ⟨10.1021/acs.jmedchem.5b01708⟩ Article dans une revue hal-01439086v1
	Accelerating small compounds discovery targeting protein-protein interaction S. Milhas , S. Betzi , P. Roche , M. Cholay , A. Restouin FEBS Journal, 2015, 282 (1, SI), pp.134 Article dans une revue hal-01439038v1
	Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia Y Collette , Thomas Prébet , A. Goubard , José Adelaïde , R Castellano Blood Cancer Journal, 2015, 5 (e292), ⟨10.1038/bcj.2015.13⟩ Article dans une revue hal-01218497v1
	A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia E Saland , H Boutzen , R Castellano , L Pouyet , E Griessinger Blood Cancer Journal, 2015, 5 (e297), ⟨10.1038/bcj.2015.19⟩ Article dans une revue hal-01219119v1
	A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells Amelie Fouque , Olivier Delalande , Mickael Jean , Remy Castellano , Emmanuelle Josselin Journal of Medicinal Chemistry, 2015, 58 (16), pp.6559-6573. ⟨10.1021/acs.jmedchem.5b00991⟩ Article dans une revue hal-01187307v1
	CD95L cell surface cleavage triggers a pro-metastatic signaling pathway in triple negative breast cancer. Marine Malleter , Sebastien Tauzin , Alban Bessede , Remy Castellano , Armelle Goubard Cancer Research, 2013, 73 (22), pp.6711-21. ⟨10.1158/0008-5472.CAN-13-1794⟩ Article dans une revue hal-00873634v1
	Stereoselective synthesis of original spirolactams displaying promising folded structures. Guilhem Chaubet , Thibault Coursindel , Xavier Morelli , Stéphane Betzi , Philippe Roche Organic & Biomolecular Chemistry, 2013, 11 (28), pp.4719-26. ⟨10.1039/c3ob40643a⟩ Article dans une revue hal-00871067v1
	The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression Marion A. Salvador , Julien Wicinski , Olivier Cabaud , Yves Toiron , Pascal Finetti Clinical Cancer Research, 2013, 19 (23), pp.6520-6531. ⟨10.1158/1078-0432.CCR-13-0877⟩ Article dans une revue hal-01431936v1
	Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts J. Gertner-Dardenne , R. Castellano , Emilie Mamessier , S. Garbit , E. Kochbati Journal of Immunology, 2012, 188 (9), pp.4701 - 4708. ⟨10.4049/jimmunol.1103710⟩ Article dans une revue hal-01765650v1
	Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix) Xiaoli Shi , Stéphane Betzi , Adrien Lugari , Sandrine Opi , Audrey Restouin FEBS Letters, 2012, 586, pp.1759-1764. ⟨10.1016/j.febslet.2012.05.017⟩ Article dans une revue hal-00717171v1
	Identification and biophysical assessment of the molecular recognition mechanisms between the human hemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X Xiaoli Shi , Sandrine Opi , Adrien Lugari , Audrey Restouin , Thibault Coursindel Biochemical Journal, 2010, 431 (1), pp.93-102. ⟨10.1042/BJ20100314⟩ Article dans une revue hal-00517249v1
	Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain and ALG-2-interacting protein X Xiaoli Shi , Sandrine Opi , Adrien Lugari , Audrey Restouin , Thibault Coursindel Biochemical Journal, 2010, 431, pp.93-102. ⟨10.1042/BJ20100314⟩ Article dans une revue hal-00600207v1
	Stereoselective ring contraction of 2,5-diketopiperazines : An innovative approach to the synthesis of promising bioactive 5-membered scaffolds Thilbault Coursindel , Audrey Restouin , Georges Dewynter , Jean Martinez , Yves Collette Bioorganic Chemistry, 2010, 38, pp.210-217. ⟨10.1016/j.bioorg.2010.05.002⟩ Article dans une revue hal-00599350v1
	Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. Sophie Reuse , Miriam Calao , Kabamba Kabeya , Allan Guiguen , Jean-Stéphane Gatot PLoS ONE, 2009, 4 (6), pp.e6093. ⟨10.1371/journal.pone.0006093⟩ Article dans une revue hal-00464770v1
	Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein. Stéphane Betzi , Audrey Restouin , Sandrine Opi , Stefan T Arold , Isabelle Parrot Proceedings of the National Academy of Sciences of the United States of America, 2007, 104 (49), pp.19256-61. ⟨10.1073/pnas.0707130104⟩ Article dans une revue hal-00473817v1
	Amine guanidine switch : a promising approach to improve DNA binding and antiproliferative activities. K. Ohara , M. Smietana , A. Restouin , S. Mollard , J.-P. Borg Journal of Medicinal Chemistry, 2007, 50, pp.6465-6475. ⟨10.1021/jm701207m⟩ Article dans une revue hal-00346603v1
	Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study Hervé Chambost , Yves Collette , Hélène Dutartre , Isabelle Thuret , Daniel Olive Leukemia Research, 2000, 24 (10), pp.823-830. ⟨10.1016/s0145-2126(00)00053-9⟩ Article dans une revue hal-02459277v1
	Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation. A Greenway , H Dutartre , K Allen , D Mcphee , D Olive Journal of Virology, 1999, 73 (7), pp.6152-8 Article dans une revue hal-02459367v1
	Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. G Zauli , D Gibellini , P Secchiero , H Dutartre , D Olive Blood, 1999, 93 (3), pp.1000-10 Article dans une revue hal-02459371v1
	Full Peptide Synthesis, Purification, and Characterization of Six Tat Variants Jean-Marie Peloponese , Yves Collette , Catherine Grégoire , Christian Bailly , Daniel Campèse Journal of Biological Chemistry, 1999, 274 (17), pp.11473-11478. ⟨10.1074/jbc.274.17.11473⟩ Article dans une revue hal-02137983v1
	The Human Immunodeficiency Virus Type 1 NEF Protein Binds the Src-Related Tyrosine Kinase Lck SH2 Domain Through a Novel Phosphotyrosine Independent Mechanism Hélène Dutartre , Mark Harris , Daniel Olive , Yves Collette Virology, 1998, 247 (2), pp.200-211. ⟨10.1006/viro.1998.9244⟩ Article dans une revue hal-02459372v1
	The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck Y. Collette , H. Dutartre , A. Benziane , D. Olive Research in virology, 1997, 148 (1), pp.52-58. ⟨10.1016/s0923-2516(97)81914-0⟩ Article dans une revue hal-02459374v1
	Similarity between Nef of primate lentiviruses and p15E of murine and feline leukaemia viruses Y. Collette , H. Dutartre , A. Benziane , D. Olive , V. Collette AIDS. Official journal of the international AIDS Society, 1996, 10 (4), pp.441. ⟨10.1097/00002030-199604000-00013⟩ Article dans une revue hal-02459381v1

	On Object-Oriented Programming of Optimizers - Examples in Scilab Y. Collette , Nikolaus Hansen , Gilles Pujol , Daniel Salazar Aponte , Rodolphe Le Riche Rajan Filomeno Coelho and Piotr Breitkopf. Multidisciplinary Design Optimization in Computational Mechanics, Wiley, pp. 499-538, 2010 Chapitre d'ouvrage inria-00476172v1

	Combinatory therapy targeting mitochondrial oxidative phosphorylation improves efficacy of IDH mutant inhibitors in acute myeloid leukemia Lucille Stuani , Marie Sabatier , Feng Wang , Nathalie Poupin , Claudie Bosc 2020 Pré-publication, Document de travail hal-02935177v1

yves collette

Présentation

Publications

C/EBPα Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress–Induced Ferroptosis in FLT3 -Mutant Leukemia

From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia

Downregulation of stromal syntenin sustains AML development

CRCM5484: A BET- BDII Selective Compound With Differential Anti-Leukemic Drug Modulation

Antimicrobial and cytotoxic effects of marine sponge extracts Agelas clathrodes, Desmapsamma anchorata and Verongula rigida from a Caribbean Island

Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell–mediated antitumor immune response

H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines

Synergy and allostery in ligand binding by HIV-1 Nef

Mitochondrial metabolism supports resistance to IDH mutant inhibitors in acute myeloid leukemia

The NANOTUMOR consortium - Towards the Tumor Cell Atlas

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells

In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor

A gain-of-function RAC2 mutation is associated with bone-marrow hypoplasia and an autosomal dominant form of severe combined immunodeficiency

ICOS is widely expressed in cutaneous T-cell lymphoma, and its targeting promotes potent killing of malignant cells

A chemogenomic approach to identify personalized therapy for patients with relapse or refractory acute myeloid leukemia: results of a prospective feasibility study

Correction to A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells

Integrated Strategy for Lead Optimization Based on Fragment Growing: The Diversity-Oriented-Target-Focused-Synthesis Approach

Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

JAM-C Identifies Src Family Kinase-Activated Leukemia-Initiating Cells and Predicts Poor Prognosis in Acute Myeloid Leukemia

Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2–JNK signalling in breast cancer

BTN3A molecules considerably improve Vγ9Vδ2T cells-based immunotherapy in acute myeloid leukemia.

Protein-Protein Interaction Inhibition (2P21)-Oriented Chemical Library Accelerates Hit Discovery

Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins

Accelerating small compounds discovery targeting protein-protein interaction

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia

A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia

A Novel Covalent mTOR Inhibitor, DHM25, Shows in Vivo Antitumor Activity against Triple-Negative Breast Cancer Cells

CD95L cell surface cleavage triggers a pro-metastatic signaling pathway in triple negative breast cancer.

Stereoselective synthesis of original spirolactams displaying promising folded structures.

The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression

Human V 9V 2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts

Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG-2-interacting protein X (Alix)

Identification and biophysical assessment of the molecular recognition mechanisms between the human hemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X

Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain and ALG-2-interacting protein X

Stereoselective ring contraction of 2,5-diketopiperazines : An innovative approach to the synthesis of promising bioactive 5-membered scaffolds

Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.

Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein.

Amine guanidine switch : a promising approach to improve DNA binding and antiproliferative activities.

Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study

Simian immunodeficiency virus and human immunodeficiency virus type 1 nef proteins show distinct patterns and mechanisms of Src kinase activation.

Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway.

Full Peptide Synthesis, Purification, and Characterization of Six Tat Variants

The Human Immunodeficiency Virus Type 1 NEF Protein Binds the Src-Related Tyrosine Kinase Lck SH2 Domain Through a Novel Phosphotyrosine Independent Mechanism

The role of HIV1 Nef in T-cell activation: Nef impairs induction of Th1 cytokines and interacts with the Src family tyrosine kinase Lck

Similarity between Nef of primate lentiviruses and p15E of murine and feline leukaemia viruses

On Object-Oriented Programming of Optimizers - Examples in Scilab

Combinatory therapy targeting mitochondrial oxidative phosphorylation improves efficacy of IDH mutant inhibitors in acute myeloid leukemia